Anthony Napolitano, Ph.D. - Strategic Healthcare Leader
Healthcare and digital health executive with expertise in health tech, medtech, AI, business development, venture capital investing, M&A, R&D, and intellectual property. Led transactions generating hundreds of millions in enterprise value.
Contact Me
Key Achievements
4
Startups Launched
Drove spin-out of four digital health and AI diagnostics startups from an academic medical center
$580M+
IPO Value
Total market cap of two successful IPOs from launched spin-outs
$250M+
Acquisition Value
Total value of two successful acquisitions from launched spin-outs
10X
Investment Return
Highest exit multiple achieved from early-stage investments
Professional Summary
Strategic Leadership
Experienced CEO and director with proven track record in healthcare innovation, digital health, and health tech development.
Deal Expertise
Led transactions valued up to $490M, generating hundreds of millions in enterprise value through strategic partnerships.
Innovation Focus
Drives innovation in medtech, digital health, and AI-driven healthcare through strategic investments and partnerships.
Current Role: Wellstand Health CEO
Since July 2021, Anthony has been transforming Wellstand Health into the leading digital pharmacy infrastructure provider and marketplace by:
  • Reinvesting profits to drive company evolution
  • Developing a nationwide ecosystem of mail-order pharmacies
  • Securing high-value government contracts
Previous Experience
1
Mount Sinai Innovation Partners (2016-2021)
As Director of Business Development & Licensing, commercialized emerging medical technologies, managed equity investments, drove spin-out of four digital health startups resulting in 2 IPOs ($580M+ market cap) and 2 acquisitions ($250M+).
2
Plymouth Capital Management (2015-2016)
As Vice President, sourced strategic investment opportunities for $20M fund and led due diligence across healthcare, biotech, digital health, and life sciences sectors.
3
Stryker Orthopaedics (2007-2015)
As Manager of Intellectual Property, directed IP strategy for multiple business units and led due diligence for M&A transactions valued up to $300M.
Education & Early Career
Academic Background
  • Ph.D., Biomedical Engineering - Brown University (2003-2007)
  • M.S./B.S., Biomedical Engineering - Columbia University (1995-2000)
Early Career
At Brown University, developed the patented "3D Petri dish" cell culture system and won $15,000 from NCIIA with his business plan.
Patents & Publications
Patents
  • Cell Aggregation and Encapsulation Device and Method
  • Toggle Bolt Suture Anchor
  • Platform for Soft Tissue Attachment
  • Apparatus for Breast Reconstruction Using Autologous Platelet-Rich Fibrin Matrix
Publications
  • Scaffold-free 3D Cell Culture Using Micro-Molded Hydrogels
  • Formation of Multi-cellular Microtissues in Biofabrication
  • Dynamics of Self-Assembly of Cellular Aggregates on Nonadhesive Hydrogels
Expertise Areas
AI in Healthcare
Expertise in AI diagnostics, predictive analytics, and machine learning applications for healthcare solutions.
Digital Health
Leading innovation in telemedicine, remote monitoring, and digital pharmacy infrastructure.
Strategic Investing
Venture capital experience with pre-seed to Series B investments and M&A transactions up to $300M.
Board Experience & Recognition
Board Service
Served as Board Member for Friends of Karen from 2017 to May 2022, supporting critically ill children and their families in the Greater New York City Area.
Awards & Recognition
  • President's Special Recognition Award (2009) at Stryker
  • Spot Award for Outstanding Contributions (May & June 2011)
  • Pharmacia Fellowship at Brown University
Connect With Anthony
Contact Information
Areas of Interest
Building connections with executives, founders, investors, and partners driving innovation in medtech, digital health, and AI-driven healthcare.
Made with